Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Randomized, Double-Masked, Vehicle-Controlled Study Evaluating the Efficacy and Safety of Licaminlimab for the Treatment of Dry Eye Disease

NCT05896670 is registered in ClinicalTrials.gov with Oculis as lead sponsor.

NCT NCT05896670
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05896670 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Randomized, Double-Masked, Vehicle-Controlled Study Evaluating the Efficacy and Safety of Licaminlimab for the Treatment of Dry Eye Disease
Lead sponsor
Oculis
Phase
Phase 2
Overall status
Completed
Start date
November 29, 2023
Completion date
March 27, 2024
Enrollment
122 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye disease